Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Clinical trial

PhaseBio
Products and Services / Research

PhaseBio Presents Data from Phase 1b/2a Trial of Pemziviptadil

February 1, 2021January 30, 2021 - by MyChesCo

MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, recently announced presentation of data from …

Read More

Verrica Pharmaceuticals Inc
Products and Services / Research

Verrica Announces Positive Topline Results in Phase 2 Clinical Study of VP-102

November 12, 2020November 12, 2020 - by MyChesCo

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, this week announced positive topline results from its Phase …

Read More
Galera Therapeutics
Cancer / Products and Services / Research

Chester County-based Biopharmaceutical Company Shares Positive Data from Pancreatic Cancer Treatment Trial

October 24, 2020October 24, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced the release of the abstract containing interim data from the first 19 patients in its pilot Phase 1/2 clinical trial designed …

Read More

U.S. Food and Drug Administration (FDA)
Health / Medical / National

FDA Awards Six Grants to Fund New Clinical Trials for the Treatment of Rare Diseases

October 12, 2020October 11, 2020 - by MyChesCo

The U.S. Food and Drug Administration recently announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over …

Read More
Annovis Bio
Products and Services / Research

Annovis Bio Begins Treatment of First Patients in its Phase 2a Alzheimer’s and Parkinson’s Trial

September 2, 2020September 2, 2020 - by MyChesCo

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced dosing of the first …

Read More

Food and Drug Administration
Government / Health / Medical / National

FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19

August 31, 2020August 31, 2020 - by MyChesCo

As part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to …

Read More
VA Announces New Clinical Trial for Veterans with COVID-19
Government / Infectious Diseases / National

VA Announces New Clinical Trial for Veterans with COVID-19

August 31, 2020August 31, 2020 - by MyChesCo

WASHINGTON, D.C.  — The Department of Veterans Affairs (VA) recently announced a new clinical trial to study convalescent plasma for treating seriously ill COVID-19 patients as part of a larger effort …

Read More

FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment
Government / Health / Medical / National

FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment

August 26, 2020August 26, 2020 - by MyChesCo

The U.S. Food and Drug Administration this week issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the …

Read More
Tower Health Enrolls Patients For COVID-19 Research Study
Health / Medical / Infectious Diseases / Research

Tower Health Enrolls Patients for COVID-19 Research Study

August 19, 2020August 19, 2020 - by MyChesCo

WEST READING, PA — Tower Health has recently enrolled 36 COVID-19 patients in the “IMmunoPhenotyping Assessment in a COVID-19 Cohort” study, or IMPACC, that aims to develop effective treatments for …

Read More
PhaseBio
Finance

PhaseBio Reports Recent Business Highlights and Second-Quarter 2020 Financial Results

August 17, 2020August 16, 2020 - by MyChesCo

MALVERN, PA  — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS) recently provided an update on corporate activities and reported second-quarter 2020 financial results.

Read More

Posts navigation

1 2 … 4 Next

Most Read

  • FTC, DOJ Temporarily Suspend Discretionary Practice of Early Termination
  • Federal Trade Commission Received 2.2 Million Fraud Reports from Consumers in 2020
  • Winter Storm Update: Heavy Snow Expected
  • Mother of Three Sentenced to 14 Years for Traveling to Pennsylvania to Have Sex with Teenager
  • Where to Enjoy the Great Outdoors in Chester County
  • One Defendant Behind Alleged Sham Health Insurance Scheme Agrees to Settle FTC Charges

Subscribe for Updates

Chester County Events

  • Women Willpower Topic: High Value Projects | Host: Lisa Morris
    • 02/09/2021
      West Chester
  • Love Dinner
    • 02/14/2021
  • Coatesville Country Club
    • 03/07/2021
      Coatesville
  • St. Patrick's Day Bar Crawl West Chester
    • 03/13/2021
      West Chester
  • HORSE SPEAK Clinic with Sharon Wilsie
    • 04/10/2021
      Coatesville
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recent Articles

  • FEMA Statement on 100% Cost Share
  • Cagent Vascular Announces PRELUDE-BTK Study Results
  • Triumph Group Reports Net Sales of $426.0 Million in Third Quarter Fiscal 2021
  • FTC, DOJ Temporarily Suspend Discretionary Practice of Early Termination
Copyright © 2021 MyChesCo.